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The genome of a wide range of viruses, including the influenza A virus, are enclosed 
in a lipid envelope. These envelopes are generally acquired in the final step of virus 
assembly. During this step viruses bud from regions of the host cell membranes where  
virally encoded membrane proteins have accumulated. The influenza A envelope is 
spiked with two glycoproteins: hemagglutinin (HA) and neuraminidase (NA). HA is 
the most abundant protein on the virus surface. It plays an important role during virus 
attachment and membrane fusion.  The mature HA forms homotrimers of a monomer 
which is initially present as a single polypeptide precursor (HA0). HA0 is 
subsequently cleaved into the subunits:  HA1 and HA2. Both subunits are glycosylated 
and each monomer contains 3 to 9 N-linked glycosylation sequins, depending on the 
virus strain. The structure of the individual glycans depends mainly on virus subtype 
and on the host cell. 
The biological function of HA-glycans is still not fully clear. However, it has been 
demonstrated that some of the glycans shield HA from proteases and neutralize 
antibodies. In addition, they play an important role in the intracellular transport of HA 
and the viral replication regulation. Structural modifications of the HA-glycans can 
influence the virus attachment to the host cell and change viral replication dynamics. 
HA-glycosylation is effected by the glycosylation machinery of the host cell system 
and can be influenced during vaccine production by choise of the host cell, 
fermentation-, inactivation- and downstream processing conditions. Therefore, it is 
important to monitor and control the glycosylation pattern over the period of the 
production process. 
In the present study we determine the HA N-glycosylation sites and glycan structure 
of the influenza A/PR/8/34 (H1N1) virus produced in Madin Darby canine kidney 
cells (MDCK) cells. Furthermore, the effect of different fermentation conditions on 
the HA-glycosylation is described. In this model the glycosylation sites of HA1 and 
HA2  are predicted ( NetNGlyc 1.0 Server ) to be  11, 23, 125 and 283, and 154 and 
312, respectively. These sites are confirmed via mass spectrometry. 
The glycan structure of the individual sites are characterized via the following 
procedure. The virus proteins are first separated by SDS-PAGE. N-glycans are 
removed in gel with PNGase F, an enzyme that cleaves Asn-linked oligosaccharides 
of oligomannosyl, hybrid and complex type. For further analysis by capillary gel 
electrophoresis (CGE) the N-glycans are labelled with 8-Aminopyrene-1,3,6-
trisulfonic acid trisodium salt (APTS) by reductive amination with NaBH3CN. CGE is 
performed on a ABI PRISM 3100-Avant genetic analyser (Applied Biosystems) by 
laser induced fluorescence. With this method, we are able to fingerprint HA N-glycan 
mixtures from cell culture produced virus with a detection limit of approximately 20 
fmol.  Additionally HA N-glycans are analyzed by mass spectrometry, carried out on 
a Quadrupol-quadrupol Time-of-flight hybrid mass spectrometer (QStarXL/Applied 
Biosystems). 
For further structural analysis of the HA N-glycans is obtained by sequential 
sequencing implementing an reagent array analysis method (RAAM). This involves 
the progressive digestion of the oligosaccharides with exoglycosidases monitored by 
CGE and mass spectrometry.  
Together, the methods demonstrated here, represent a  promising tool to monitor HA-
glycosylation during the most important steps in upstream and downstream 
processing of influenza virus for vaccine production. 
 
 
 
